In this episode, host Shikha Jain, MD, speaks with Brian Fiske about bringing biotech business ideas to fruition, antibody drug conjugate developments and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Fiske 0:21 • The interview 1:45 • How did you get to where you are today, and how did you become interested in this specific area of health care? 2:06 • What is a timeline from start to finish to bringing an innovative idea to fruition? 6:01 • How long does it take to form an actual company from an idea? 11:20 • How do you figure out who you need on your team to move an idea forward? 15:11 • Tell us about your previous positions at biotech companies, and how did they help lead you into your current space? 20:22 • What excites you about your job? […] Why do you feel the drive and desire to do this type of work? 24:40 • Where do you see the work at Mythic Therapeutics doing in the next five to ten years for patient care? 26:27 • How can we work towards making sure this type of innovative work is available and accessible to patients? 29:20 • If someone could only listen to the last few minutes of this episode, what would you want them to take away? 31:16 • How to contact Fiske 32:12 • Thanks for listening 32:56 Brian Fiske is chief scientific officer and co-founder of Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate therapies for the treatment of a wide range of cancers.
We’d love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Fiske can be reached via LinkedIn or the Mythic Therapeutics website. Disclosures: Jain and Fiske report no relevant financial disclosures.